Track Cancer’s Most Critical Moments
Numerous genomic events and complex clonality in multiple myeloma (MM) render it a challenging disease with a high relapse rate despite advancements in therapies and diagnostic approaches.
Tapestri single-cell multiomics analysis can transform how to tackle the complexities of multiple myeloma and its precursor stages by integrating genomic, proteomic, and clonotypic subclonal assessment with single-cell resolution, all within a single assay.
With the Tapestri Single-cell Multiple Myeloma Multiomics Solution, you gain crucial insights into the clonal heterogeneity and evolution underlying myeloma progression, therapy response, and relapse often overlooked by traditional bulk methods, potentially informing the development of better therapies and combination therapy regimens.
Hotspot Mutations in Driver & Resistance Genes
Assess clonal heterogeneity & evolution in Multiple Myeloma (includes SNV and focal CNA)
Discern zygosity of detected mutations impacting disease progression or drug resistance
Analyze whole
genome copy number gains and losses
Identify Ig clonotype in the CDR3 region
Classify cell types and identify immunotherapy targets such as BCMA
